Drug recall · December 24, 2025
OraVerse recall
Why: Defective container: cracked/broken cartridges
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10
- Lots / codes
Lot: D05004E, expires: 04-30-2027
- Quantity
- 1,636 cartons
- Company
- Novocol Pharmaceutical of Canada, Inc., Cambridge
- Distribution
- U.S.A. Nationwide
- Initiated
- October 31, 2025 · Voluntary: Firm initiated
- Classified
- December 12, 2025
- Reported
- December 24, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phentolamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.